Endo International plc [NASDAQ: ENDP] price plunged by -3.15 percent to reach at -$0.13. The company report on December 23, 2021 that Endo Reaches Agreement Intended to Settle Texas Governmental Opioid Cases and Claims.
Endo International plc (NASDAQ: ENDP) (“Endo”) today announced that it and its wholly-owned subsidiaries Endo Pharmaceuticals Inc., Endo Health Solutions Inc., Par Pharmaceutical, Inc., and Par Pharmaceutical Companies, Inc. have entered into a statewide settlement agreement intended to resolve all government-related opioid claims in Texas.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
The settlement, which is subject to certain conditions and contingencies, provides a framework through which Endo and its subsidiaries can fully and finally resolve the opioid-related claims of Texas and its subdivisions in exchange for a total payment of $63 million. The settlement includes no admission of wrongdoing, fault or liability of any kind by Endo or its subsidiaries, and the settlement value should not be extrapolated to any other opioid-related cases or claims.
A sum of 3379879 shares traded at recent session while its average daily volume was at 7.19M shares. Endo International plc shares reached a high of $4.145 and dropped to a low of $3.95 until finishing in the latest session at $4.00.
The one-year ENDP stock forecast points to a potential upside of 37.5. The average equity rating for ENDP stock is currently 3.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Endo International plc [ENDP]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ENDP shares is $6.40 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ENDP stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Piper Sandler have made an estimate for Endo International plc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on August 31, 2021. While these analysts kept the previous recommendation, RBC Capital Mkts raised their target price to Sector Perform. The new note on the price target was released on April 07, 2021, representing the official price target for Endo International plc stock. Previously, the target price had yet another raise to $3, while Goldman analysts kept a Sell rating on ENDP stock.
The Average True Range (ATR) for Endo International plc is set at 0.35, with the Price to Sales ratio for ENDP stock in the period of the last 12 months amounting to 0.31. Price to Free Cash Flow for ENDP in the course of the last twelve months was 1.85 with Quick ratio for the last quarter at 1.60.
ENDP Stock Performance Analysis:
Endo International plc [ENDP] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 6.95. With this latest performance, ENDP shares dropped by -31.39% in over the last four-week period, additionally sinking by -16.32% over the last 6 months – not to mention a drop of -36.91% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ENDP stock in for the last two-week period is set at 35.45, with the RSI for the last a single of trading hit 34.28, and the three-weeks RSI is set at 38.79 for Endo International plc [ENDP]. The present Moving Average for the last 50 days of trading for this stock 5.12, while it was recorded at 4.09 for the last single week of trading, and 4.90 for the last 200 days.
Insight into Endo International plc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Endo International plc [ENDP] shares currently have an operating margin of +20.78 and a Gross Margin at +50.31. Endo International plc’s Net Margin is presently recorded at +8.52.
Return on Total Capital for ENDP is now 7.85, given the latest momentum, and Return on Invested Capital for the company is 3.24. Additionally, ENDP Total Debt to Total Capital is recorded at 108.36, with Total Debt to Total Assets ending up at 90.62.
Reflecting on the efficiency of the workforce at the company, Endo International plc [ENDP] managed to generate an average of $72,848 per employee. Receivables Turnover for the company is 5.32 with a Total Asset Turnover recorded at a value of 0.31.Endo International plc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.60 and a Current Ratio set at 1.80.
ENDP Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ENDP. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Endo International plc go to -13.40%.
Endo International plc [ENDP] Insider Position Details
There are presently around $728 million, or 76.20% of ENDP stock, in the hands of institutional investors. The top three institutional holders of ENDP stocks are: BLACKROCK INC. with ownership of 36,427,206, which is approximately -1.252% of the company’s market cap and around 1.54% of the total institutional ownership; VANGUARD GROUP INC, holding 25,087,294 shares of the stock with an approximate value of $103.61 million in ENDP stocks shares; and PAULSON & CO. INC., currently with $71.56 million in ENDP stock with ownership of nearly -5.456% of the company’s market capitalization.
Positions in Endo International plc stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 88 institutional holders increased their position in Endo International plc [NASDAQ:ENDP] by around 18,728,699 shares. Additionally, 113 investors decreased positions by around 32,170,337 shares, while 30 investors held positions by with 125,299,614 shares. The mentioned changes placed institutional holdings at 176,198,650 shares, according to the latest SEC report filing. ENDP stock had 29 new institutional investments in for a total of 3,595,585 shares, while 48 institutional investors sold positions of 7,254,169 shares during the same period.